CD8 + T cell exhaustion and its regulatory mechanisms in the tumor microenvironment: key to the success of immunotherapy

A steady dysfunctional state caused by chronic antigen stimulation in the tumor microenvironment (TME) is known as CD8 T cell exhaustion. Exhausted-like CD8 T cells (CD8 Tex) displayed decreased effector and proliferative capabilities, elevated co-inhibitory receptor generation, decreased cytotoxici...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 15; p. 1476904
Main Authors Zhang, Biao, Liu, Jinming, Mo, Yuying, Zhang, Kexin, Huang, Bingqian, Shang, Dong
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 20.09.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A steady dysfunctional state caused by chronic antigen stimulation in the tumor microenvironment (TME) is known as CD8 T cell exhaustion. Exhausted-like CD8 T cells (CD8 Tex) displayed decreased effector and proliferative capabilities, elevated co-inhibitory receptor generation, decreased cytotoxicity, and changes in metabolism and transcription. TME induces T cell exhaustion through long-term antigen stimulation, upregulation of immune checkpoints, recruitment of immunosuppressive cells, and secretion of immunosuppressive cytokines. CD8 Tex may be both the reflection of cancer progression and the reason for poor cancer control. The successful outcome of the current cancer immunotherapies, which include immune checkpoint blockade and adoptive cell treatment, depends on CD8 Tex. In this review, we are interested in the intercellular signaling network of immune cells interacting with CD8 Tex. These findings provide a unique and detailed perspective, which is helpful in changing this completely unpopular state of hypofunction and intensifying the effect of immunotherapy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Jindong Xie, Sun Yat-sen University Cancer Center (SYSUCC), China
Reviewed by: Farah Alfatyan, MUSC Health, United States
These authors have contributed equally to this work
Edited by: Xiangyu Chen, Chongqing Medical University, China
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2024.1476904